Dark

KALV
KalVista Pharmaceuticals, Inc. Common Stock
stock NASDAQ

Market Open

Apr 29, 2026 1:21:45 PM EDT

26.70USD+38.799%(+7.46)50,289,359

26.70Bid 26.71Ask 0.01Spread

Pre-market

Apr 29, 2026 9:28:30 AM EDT

26.70USD+38.773%(+7.46)5,702,780

After-hours

Apr 28, 2026 4:00:30 PM EDT

19.24USD0.000%(0.00)0

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

1.37B

CEO

Thomas Crockett

Headquarters

Cambridge, Massachusetts, USA

Industry

Biotechnology

Last Split

Nov 22, 20161for14reverse

XENT EYEG KOOL SNOA XLV

KALV Stats

Avg. Vol. 10 Day

1,167,577

Avg. Vol. 30 Day

1,169,697

Employees

Market Cap

1,367,640,403

Shares Out.

51,222,487

On/Off Exchange

55%/45%

6 Month Beta

1.00

1 Year Beta

0.81

2 Year Beta

0.86

3 Year Beta

0.81

52 Week Low

9.83

52 Week High

21.31

SMA50

17.91

SMA200

14.90

1 Week

+36.50%

1 Month

+45.43%

3 Month

+70.61%

6 Month

+143.61%

1 Year

+104.13%

2 Year

+142.51%

5 Year

+5.83%

Profile

kalvista is a clinical stage pharmaceuticals company focused on the discovery, development, and commercialization of small molecule protease inhibitors.

KALV Stock Summary

KalVista Pharmaceuticals, Inc. Common Stock (NASDAQ:KALV) stock price today is $26.70, and today's volume is 50,289,359. KALV is up 38.799% today. The 30 day average volume is 1,169,697. KALV market cap is 1.37B with 51,222,487 shares outstanding.